China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$3.00+0.27 (+9.89%)
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
China SXT Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2026 it was -545.2%, against -189.8% the year before. The highest annual figure on record is 24.3% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -545.2% | −355.5 |
| FY2025 | Mar 31, 2025 | -189.8% | −29.1 |
| FY2024 | Mar 31, 2024 | -160.7% | +140.3 |
| FY2023 | Mar 31, 2023 | -301.0% | −80.6 |
| FY2022 | Mar 31, 2022 | -220.4% | −162.9 |
| FY2021 | Mar 31, 2021 | -57.5% | +141.8 |
| FY2020 | Mar 31, 2020 | -199.3% | −221.2 |
| FY2019 | Mar 31, 2019 | 22.0% | +5.0 |
| FY2018 | Mar 31, 2018 | 16.9% | −7.4 |
| FY2017 | Mar 31, 2017 | 24.3% | – |
See a number that looks wrong?